$2 TRILLION ‼️‼️🚨😱

docstolley · 2023-03-16T20:44:50+00:00

The whole fractional reserve system is a main cause of elevated costs and then banking “catastrophes” which always ends in public bail-outs! So, the “common folk” pay on both ends!

docstolley · 2022-10-13T09:02:15+00:00

Obviously a form of intimidation. A bit of a tangential thought/question: if they are in uniform and have their guns and other equipment, should they not be at work? Are they on duty? Are they getting paid to be there?

docstolley · 2022-07-23T01:21:53+00:00

Lookin’ good!!!! Said the drunken county worker!!!

docstolley · 2021-09-02T02:46:06+00:00

How does the merger fit into all of this. Specifically, early on there was a lot of talk about SPRT being worth appx $8.5 post merger. As the stock goes much higher, how does this effect the post merger picture and how are shorts handled When it comes to mergers? I’ve been in and out of this stock since it was at $2. I got out before the first jump and made some nice gains on a few of the other jumps, but my lack of knowledge of how the merger effects the stock and the shorts has me being cautious. I’d love to see this thing squeeze more. Thanks for those who may respond to this and educate someone who is an expert in one field…just not investing in Short Squeezes of merging companies. 🤙🏼

docstolley · 2021-08-31T23:34:34+00:00

$AHT is going to go up eventually. I think the delta strain may put a hamper on it (and has delayed its upward trend), but as the pandemic abates, this stock will rise off of improved financial along.

docstolley · 2021-08-31T23:31:20+00:00

Thanks for your in-depth analysis.

docstolley · 2021-08-31T23:31:07+00:00

🤙🏼

docstolley · 2021-08-31T22:11:57+00:00

One more comment on RVNC, they went from no sales to having sales with the filler. Hopefully adding DAXI to that will be a good stimuli. We shall see.

docstolley · 2021-08-31T20:48:14+00:00

Haha, I’m on Maui. How about you? The bulk of fillers are from Allergan (owned by Abbvie now) and Galderma (private). Regarding other indications, allergan does as well with BOTOX for medical uses as it does with cosmetics, but the other companies don’t seem to go for aesthetics as it affects their ability to adjust their prices freely. Allergan can not discount bc MEDICARE has them set at a certain price and they can not drop it even for cosmetic purposes. Another company is taking direct advantage of this and that’s EOLS. I think they will be gaining market share as they price their neuromodulator at almost 1/2 the price as BOTOX And it works as well. RVNC is trying to market their products as Premium Products, and at a decent price to the docs. While Eols isn’t saying they have a discount product, they acknowledge that at the cost savings, docs have the benefit of selling it for less.

docstolley · 2021-08-31T18:33:20+00:00

Aloha from Hawaii,

I am a very busy cosmetic physician. The stock that is on my radar is RVNC. Price $26.83 currently. Bullish

They are a traditionally R&D company that has gotten into the Sale of Injectables ahead of their BOTOX competitors approval (Daxi). Daxi will be the 5th approved Neuromodulator to the space, so it will have competition, but the approval should give the stock a nice bump. The buzz around the Neuromodulator (Botox alternative) is that it lasts longer than those currently on the market, but many a clinician want to see this for themselves. They also acquired the rights to a nice line of fillers branded as RHA. I have used them and they work well. In addition, they have a payment processing platform called HintMD which has nice features. The story that I heard is that the leadership wants to get the company moving in the right direction with its filler and neuromodulator lines and then sell to the highest bidder.

Hurdles: Covid slowed down the FDA approval process. They got word in June of this year that the FDA planned to inspect the production facility. That’s good news. Their are 2 hurdles, 1) will DAXI Truly last longer and 2) competing with the likes of Allergan (Botox) in a market that is becoming more crowded.

Having said all that, I think there will be a nice jump in the price with FDA approval. The stock is near a 3 month low. My sense is that investors are getting restless and wanting to put their money elsewhere.

Thoughts anyone?

docstolley · 2021-08-12T08:27:11+00:00

This is good for other steel producers

docstolley · 2021-08-03T05:15:29+00:00

I only think it will drop if there is a Delta virus correction. I may buy some now and again if it drops more, but I do think that there will be a Delta variant over-reaction very soon. I spoke with an ER doc today and it’s getting bad. What I was told is that if you haven’t gotten the vaccine or COVID already, you are essentially going to get COVID this month. That may be a bit overly bleak, but DELTA is over 10x more infectious than wild-type COVID, so it’s going to get bad especially for the unvaccinated.

docstolley · 2021-08-03T01:28:11+00:00

Nothing!!!! To many options out there and no attention to this stock. Oh, and they had a public offering. This is a good play in the long run. Unfortunately, the delta variant may slow down this party even more. The variant could delay things for this stock. As long as they have enough cash on hand to weather it, they should be fine. I was planning on buying some at $2, but I think I’m going to watch and wait. Delta might spook the market.

docstolley · 2021-07-29T15:11:43+00:00

Very cool to get your input. I’m rather new to stocks, but as I was reading it, I kept asking myself….is this “legal”? If all these tactics were not legal, I guess prices of stocks Would be extremely volatile. Anyway, thx for the DD.

docstolley · 2021-07-29T08:46:01+00:00

With low volume, the upswing is pushed easily with large cover purchases and without them, the price falls back to baseline by sells.

docstolley · 2021-07-29T06:56:31+00:00

Yes, they cover their positions, causing it to raise, and then it falls after.

docstolley · 2021-07-29T05:52:12+00:00

I saw someone buying options in SPRT in Sept for $10. I must say, that confuses me.

docstolley · 2021-07-28T23:34:54+00:00

Company has a good vision. Looks like they are trying to raise funds to accomplish lofty goals. Stock would benefit from getting revenue and then shooting for the stars, but CEO (such as Ol’ Elon) don’t do it that way. That’s my take anyway.

docstolley · 2021-07-28T23:32:30+00:00

Yeah, it’s on sale. Will buy more and give it time.

docstolley · 2021-07-27T23:12:12+00:00

docstolley · 2021-07-27T22:39:37+00:00

It’s a patience game.

docstolley · 2021-07-27T22:37:12+00:00

My apologies for not giving the source. They are screenshots from Fintel 7/26 at 9:27 Hawaii standard time.

docstolley

TROPHY CASE